Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Open Labeled Trial of Disulfiram With Copper in Metastatic Breast Cancer

NCT03323346 is registered in ClinicalTrials.gov with The Institute of Molecular and Translational Medicine, Czech Republic as lead sponsor.

NCT NCT03323346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03323346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Open Labeled Trial of Disulfiram With Copper in Metastatic Breast Cancer
Lead sponsor
The Institute of Molecular and Translational Medicine, Czech Republic
Phase
Phase 2
Overall status
Completed
Start date
September 29, 2017
Completion date
December 30, 2025
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasm female, metastatic breast cancer